ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
8 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
54K
|
8
|
|
ASX - By Stock
|
AZL |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
cuppa
|
19 |
6.3K |
1 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
19
|
6.3K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
11 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
54K
|
11
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
1 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
54K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
6 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
107
|
54K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
11 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
107
|
54K
|
11
|
|
Sport
|
|
Re:
AFL
|
|
cuppa
|
1.5K |
222K |
0 |
25/07/24 |
25/07/24 |
Sport
|
1.5K
|
222K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
9 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
54K
|
9
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
2 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
107
|
54K
|
2
|
|
ASX - By Stock
|
EUR |
Re:
Ann: CRML Completes Stage 1 Investment for Tanbreez Acquisition
|
|
cuppa
|
19 |
6.3K |
0 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
19
|
6.3K
|
0
|
|
Sport
|
|
Re:
AFL
|
|
cuppa
|
1.5K |
222K |
1 |
23/07/24 |
23/07/24 |
Sport
|
1.5K
|
222K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
8 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
107
|
54K
|
8
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
11 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
107
|
54K
|
11
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
3 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
107
|
54K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
0 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
107
|
54K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW June 2024 quarterly activity report & Appendix 4C
|
|
cuppa
|
62 |
17K |
9 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
62
|
17K
|
9
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
0 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
107
|
54K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW June 2024 quarterly activity report & Appendix 4C
|
|
cuppa
|
62 |
17K |
11 |
22/07/24 |
22/07/24 |
ASX - By Stock
|
62
|
17K
|
11
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: LU7 Board Visits Operating Refineries in China
|
|
cuppa
|
41 |
24K |
4 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
41
|
24K
|
4
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
0 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
107
|
54K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
0 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
107
|
54K
|
0
|
|
ASX - By Stock
|
AZL |
Re:
Ann: $21 Million Investment Incentive for the Prairie Project
|
|
cuppa
|
73 |
26K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
73
|
26K
|
2
|
|
ASX - By Stock
|
AZL |
Re:
Ann: $21 Million Investment Incentive for the Prairie Project
|
|
cuppa
|
73 |
26K |
5 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
73
|
26K
|
5
|
|
ASX - By Stock
|
AZL |
Re:
Ann: Lithium Discovery at Prairie
|
|
cuppa
|
79 |
24K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
79
|
24K
|
2
|
|
ASX - By Stock
|
AZL |
Re:
Ann: $21 Million Investment Incentive for the Prairie Project
|
|
cuppa
|
73 |
26K |
1 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
73
|
26K
|
1
|
|
ASX - By Stock
|
AZL |
Re:
Ann: Lithium Discovery at Prairie
|
|
cuppa
|
79 |
24K |
1 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
79
|
24K
|
1
|
|
ASX - By Stock
|
AZL |
Re:
Ann: Lithium Discovery at Prairie
|
|
cuppa
|
79 |
24K |
7 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
79
|
24K
|
7
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Diamond drilling commences at CODA
|
|
cuppa
|
61 |
15K |
2 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
61
|
15K
|
2
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Diamond drilling commences at CODA
|
|
cuppa
|
61 |
15K |
0 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
61
|
15K
|
0
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Diamond drilling commences at CODA
|
|
cuppa
|
61 |
15K |
1 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
61
|
15K
|
1
|
|
ASX - By Stock
|
MMR |
Re:
Ann: Reinstatement to trading update
|
|
cuppa
|
24 |
7.5K |
2 |
13/07/24 |
13/07/24 |
ASX - By Stock
|
24
|
7.5K
|
2
|
|
ASX - By Stock
|
ENV |
Re:
Ann: Director fees and CEO remuneration
|
|
cuppa
|
18 |
4.2K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
18
|
4.2K
|
6
|
|
Charts
|
ACW |
Re:
ACW Chart Thread
|
|
cuppa
|
138 |
58K |
5 |
09/07/24 |
09/07/24 |
Charts
|
138
|
58K
|
5
|
|
Sport
|
|
Re:
AFL
|
|
cuppa
|
1.5K |
222K |
4 |
05/07/24 |
05/07/24 |
Sport
|
1.5K
|
222K
|
4
|
|
ASX - By Stock
|
EUR |
Re:
Ann: Obeikan Group executes Shareholder Agreement
|
|
cuppa
|
30 |
10K |
1 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
30
|
10K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Biden to volunteer for Xanamem trial ?
|
|
cuppa
|
7 |
2.2K |
1 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
7
|
2.2K
|
1
|
|
ASX - By Stock
|
ACW |
Re:
Biden to volunteer for Xanamem trial ?
|
|
cuppa
|
7 |
2.2K |
3 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
7
|
2.2K
|
3
|
|
ASX - By Stock
|
AZL |
Re:
AZL General Discussion
|
|
cuppa
|
23K |
8.3M |
2 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
23K
|
8.3M
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: ACW XanaCIDD depression trial results expected early August
|
|
cuppa
|
107 |
54K |
1 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
107
|
54K
|
1
|
|
Sport
|
|
Re:
AFL
|
|
cuppa
|
1.5K |
222K |
3 |
01/07/24 |
01/07/24 |
Sport
|
1.5K
|
222K
|
3
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
33K |
0 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
88
|
33K
|
0
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
33K |
5 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
88
|
33K
|
5
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
33K |
6 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
88
|
33K
|
6
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
33K |
5 |
29/06/24 |
29/06/24 |
ASX - By Stock
|
88
|
33K
|
5
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: LU7 Board Visits Operating Refineries in China
|
|
cuppa
|
41 |
24K |
2 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
41
|
24K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
33K |
2 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
88
|
33K
|
2
|
|
ASX - By Stock
|
ACW |
Re:
Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis
|
|
cuppa
|
88 |
33K |
6 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
88
|
33K
|
6
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Prospectus
|
|
cuppa
|
4 |
2.6K |
2 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
4
|
2.6K
|
2
|
|
ASX - By Stock
|
LU7 |
Re:
Ann: Prospectus
|
|
cuppa
|
4 |
2.6K |
4 |
24/06/24 |
24/06/24 |
ASX - By Stock
|
4
|
2.6K
|
4
|
|
ASX - By Stock
|
AZL |
Re:
Why do folks only post on a single stock? Beware the pumpers!
|
|
cuppa
|
30 |
6.9K |
4 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
30
|
6.9K
|
4
|
|